Kristen Rice, MD
Dermatology · Tulsa, OKNPI 1871826115
Payments from drug & device makers
Across 479 payments — averaging $118.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Research & Development, LLC$45K
- Dermavant Sciences, Inc.$3K
- AbbVie$2K
- E.r. Squibb & Sons, L.L.C.$765
- Novartis$719
- Johnson & Johnson$694
- plus $5K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Research & Development, LLC | 12 | $45,064 |
| Dermavant Sciences, Inc. | 37 | $2,752 |
| AbbVie(2 entities) | 70 | $2,138 |
| E.r. Squibb & Sons, L.L.C. | 36 | $765 |
| Novartis | 38 | $719 |
| Johnson & Johnson | 36 | $694 |
| Amgen | 31 | $651 |
| Lilly USA, LLC | 21 | $531 |
| Arcutis Biotherapeutics, Inc. | 39 | $399 |
| UCB, Inc. | 19 | $398 |
| Sun Pharmaceutical Industries Inc. | 19 | $356 |
| Pfizer | 18 | $314 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $264 |
| LEO Pharma Inc. | 11 | $214 |
| Galderma Laboratories, L.p. | 13 | $213 |
| Regeneron Healthcare Solutions, Inc. | 10 | $179 |
| VYNE Pharmaceuticals Inc. | 6 | $147 |
| Almirall LLC | 7 | $145 |
| Sanofi | 6 | $138 |
| Bristol Myers Squibb | 12 | $130 |
| Mayne Pharma Commercial LLC | 10 | $119 |
| Conmed Corporation | 1 | $73 |
| Boehringer Ingelheim | 4 | $58 |
| Dermira, Inc. | 2 | $39 |
| Prugen, Inc. Pharmaceuticals | 3 | $36 |
| Sandoz | 2 | $34 |
| DUSA Pharmaceuticals, Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $17 |
| Botanix SB Inc | 1 | $15 |
| Organon | 1 | $11 |
How this compares
$56,676 in reported general payments places this provider in the 90th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Tulsa
- Alison FischerTulsa$1.5M
- George MonksTulsa$530K
- Jeff AlexanderTulsa$41K
- Johnathan LedetTulsa$37K
- John AshleyTulsa$24K
- Mark LehmanTulsa$17K
- Kelli LovelaceTulsa$14K
- Bernard RobinowitzTulsa$14K
- Christina KendrickTulsa$13K
- Ashwini VaidyaTulsa$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.